Selection of a SARS-CoV-2 antibody quantification method and development of an antibody reference standard for ELISA to test immunoglobulin preparations
The development of COVID-globulin, a COVID-19-specific human immunoglobulin preparation, involved choosing a method to quantify antibodies to SARS-CoV-2. Antibody titre determination by virus neutralisation (VN) is labour-intensive and unsuitable for large-scale application. To enable routine testin...
Main Authors: | T. I. Smolyanova, A. M. Nikolaeva, T. V. Vyaznikova, A. V. Ivanov, O. V. Belyakova, E. I. Sakanyan |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Ministry of Health of the Russian Federation. Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products»
2022-12-01
|
Series: | Биопрепараты: Профилактика, диагностика, лечение |
Subjects: | |
Online Access: | https://www.biopreparations.ru/jour/article/view/420 |
Similar Items
-
Development of an in-house reference standard for anti-rabies immunoglobulin potency, to be used in the virus neutralisation test in a Vero cell culture
by: E. G. Abramova, et al.
Published: (2022-04-01) -
Mechanisms of Rhinovirus Neutralisation by Antibodies
by: Lila Touabi, et al.
Published: (2021-02-01) -
Fundamental differences between natural antibodies and polyreactive immunoglobulins
by: S. A. Bobrovnik, et al.
Published: (2015-10-01) -
Human anti-D immunoglobulin preparations: potency standardisation milestones
by: N. S. Vildanova, et al.
Published: (2022-10-01) -
Development and comparison of different versions of ELISA for detection of specific IgE-antibodies
by: O. Galkin, et al.
Published: (2016-11-01)